Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 06 Mar 2023
USA: The syrup drug Diethylene glycol (DEG), a drug commonly used to prevent infections, is the cause of kidney disease...
Read Full News1.
For the first time in humans, a chemotherapy drug reaches the brain.
2.
Hair Growth After Cancer; 'Global' Early-Onset CRC; Retifanlimab Boosts OS in NSCLC
3.
FDA Approves Orca‑T, a Next‑Gen HSCT to Reduce GVHD
4.
Distribution of fat could influence cancer risk, study suggests
5.
Good News for CAR-T Therapy; Liquid Biopsy Progress; Anti-Psychotic for Brain Cancer
1.
Multiple Myeloma: Understanding the Basics
2.
Unlocking the Potential of SCD: A Comprehensive Guide to Diagnosis and Treatment
3.
The latest research on Iron Binding Capacity: The Little-Known Factor That Could Impact Your Health v
4.
Tumor Ecosystem Modulation in Precision Oncology
5.
Essential Strategies in Hematology for Healthcare Excellence
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V
2.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V
3.
Hands-on Workshop: Hematology
4.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
5.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge